Develop and Test HIV Prevention Interventions for Black and Hispanic Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Substances
ID: 355904Type: Posted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$350K - $475K

Eligible Applicants

For-Profit Organizations

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355904
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) has announced a Notice of Funding Opportunity (NOFO) titled "Develop and Test HIV Prevention Interventions for Black and Hispanic Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Substances." This initiative aims to support pilot research focused on developing and testing behavioral implementation strategies for biomedical interventions, such as oral PrEP and condom use, to enhance HIV and STI prevention among disproportionately affected populations, particularly Black and Hispanic men who have sex with men (MSM) who report substance use. The funding, totaling $2.85 million, is intended for a three-year performance period, with two awards expected, each ranging from $350,000 to $475,000. Interested applicants must submit their proposals by February 20, 2025, with the project anticipated to commence on September 1, 2025. For further inquiries, applicants can contact Jocelyn Patterson Mosley at JPatterson@cdc.gov.

    Point(s) of Contact
    JPatterson@cdc.gov
    Files
    Title
    Posted
    RFA-PS-25-113_20241216.pdf
    The Centers for Disease Control and Prevention (CDC) has issued a Notice of Funding Opportunity (NOFO) aimed at developing and testing HIV prevention interventions specifically for Black and Hispanic men who have sex with men (MSM) who use substances. Identified as RFA-PS-25-113, this initiative seeks to address significant health disparities in HIV infection rates within these populations. A total of $2.85 million is allocated for a three-year performance period, with two awards expected, each supporting the development and evaluation of culturally competent strategies that enhance PrEP (Pre-exposure prophylaxis) adherence and condom use. The funding allows eligible institutions to conduct research that meets CDC's Best Evidence framework, focusing on encouraging sexual protective behaviors in priority jurisdictions outlined in the “Ending the HIV Epidemic” (EHE) initiative. Applications are encouraged from various organizations, with a strong emphasis on partnerships with community-based groups and health departments. The project aims to assess and potentially expand successful interventions into officially endorsed programs for widespread community implementation, thereby contributing to national goals for reducing HIV infections. The application deadline is set for February 20, 2025, with an intended start date of September 1, 2025.
    Similar Opportunities
    Demonstration Projects for Comprehensive and Integrated HIV Care, Treatment, Prevention and Essential Support Service Models for Cis-gender Black Women (CgBW) in the South
    Centers for Disease Control - NCHHSTP
    The Centers for Disease Control and Prevention (CDC) is forecasting a grant opportunity titled "Demonstration Projects for Comprehensive and Integrated HIV Care, Treatment, Prevention and Essential Support Service Models for Cis-gender Black Women (CgBW) in the South." This initiative aims to address the significant health disparities faced by CgBW, who represent the largest percentage of women living with HIV in the U.S., by funding organizations to implement integrated care service models through Community and Clinic Collaboratives (CCCs). The project will focus on providing comprehensive health services, including HIV care, mental health support, and essential services, while fostering culturally responsive practices and sharing best practices through a national learning collaborative. The estimated total program funding is $7.5 million, with three awards expected, and applications must be submitted electronically by March 28, 2025, to be considered for funding. For further inquiries, interested applicants can contact Jerris Raiford at (770) 488-0691 or via email at HRBNOFO@cdc.gov.
    HIV Prevention and Alcohol (R01 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HIV Prevention and Alcohol (R01 Clinical Trials Optional)" aimed at expanding HIV prevention strategies among populations affected by alcohol use. This initiative encourages research projects that explore the relationship between alcohol consumption and HIV risk behaviors, focusing on areas such as Pre-exposure Prophylaxis (PrEP) utilization, Treatment as Prevention (TasP), and the integration of preventive intervention strategies. The program is particularly significant for addressing health disparities among high-risk groups, including men who have sex with men (MSM) and women with high-risk partners. The NIH anticipates funding between $2 million for 2 to 4 awards, with a project period of up to five years. Interested applicants can submit their proposals through the NIH ASSIST system or Grants.gov, and should direct inquiries to grantsinfo@nih.gov. The application deadline is May 7, 2026.
    Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances" under the R34 planning grant mechanism. This initiative aims to encourage formative research and the development of innovative interventions that target HIV prevention and care, particularly for populations that engage in substance use, addressing critical gaps in HIV care and prevention. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofit entities, and tribal governments, with grants available for up to $450,000 over three years. The application cycle begins on April 7, 2025, with subsequent due dates throughout the year, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Integrated HIV Programs for Tennessee Community-Based Organizations to Support Ending the HIV Epidemic in the United States
    Centers for Disease Control - NCHHSTP
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Integrated HIV Programs for Tennessee Community-Based Organizations to Support Ending the HIV Epidemic in the United States." This cooperative agreement aims to implement a comprehensive HIV prevention program that complements existing initiatives, such as the Ryan White program, to prevent new HIV infections and improve health outcomes for individuals living with HIV in Tennessee. Community-based organizations (CBOs) are expected to play a crucial role in enhancing service delivery, increasing HIV diagnosis, and facilitating access to preventive and care services. The estimated total program funding is $20 million, with two awards anticipated, and applications must be submitted electronically by February 11, 2025. For further inquiries, interested parties can contact Erica K. Dunbar at 800-232-4636 or via email at NOFOINFO@cdc.gov.
    HIV Prevention and Alcohol (R01 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "HIV Prevention and Alcohol (R01 Clinical Trials Optional)" aimed at enhancing the HIV/AIDS prevention toolkit for populations impacted by alcohol use. This initiative seeks to integrate effective prevention and treatment interventions while developing and testing new strategies to address the behavioral and biological risks associated with HIV acquisition, particularly among high-risk groups such as men who have sex with men and transgender individuals. The anticipated funding for fiscal year 2025 is $2 million, with 2-4 awards expected, and applications must be submitted through Grants.gov by May 7, 2026. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information page at https://grants.nih.gov/grants/guide/pa-files/PAS-25-208.html.
    HIV Prevention and Alcohol (R34 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), has announced a Notice of Funding Opportunity (NOFO) titled "HIV Prevention and Alcohol (R34 Clinical Trials Optional)." This initiative aims to enhance the HIV prevention toolkit for populations affected by alcohol consumption, focusing on the integration of effective prevention and treatment interventions to reduce the incidence of new HIV infections. The program is particularly relevant for high-risk groups, including men who have sex with men, transgender individuals, and others impacted by alcohol-related HIV transmission, emphasizing the need for innovative strategies to address health disparities. The funding opportunity offers a total estimated program funding of $1.5 million for 2-4 awards, with individual project budgets capped at $450,000, and applications are due by May 7, 2026. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and should refer to the full announcement for detailed application guidelines.
    High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)" aimed at supporting innovative research that addresses the intersection of HIV and substance use. This initiative invites applications from individual researchers and research teams to develop projects that can lead to new prevention, treatment, and care strategies for individuals affected by both conditions, with a requirement for a detailed research plan and preliminary data. A total budget of $3.0 million is available for funding one to two awards, with individual project budgets capped at $1.5 million per fiscal year, and applications are due by February 12, 2027. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to consult with NIDA program staff early in the application process.
    Addressing Stigma to End the HIV Epidemic in the U.S.
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is offering a funding opportunity titled "Addressing Stigma to End the HIV Epidemic in the U.S." aimed at supporting an organization that will implement, train, and evaluate anti-stigma interventions to enhance access to HIV care for underserved populations. The selected recipient will manage approximately 20 demonstration sites, facilitate national training, and develop a robust evaluation framework to assess the impact of these interventions over a four-year performance period, with a total funding amount of $25.25 million. This initiative is crucial for improving health outcomes by reducing stigma within healthcare systems, thereby increasing the availability of high-quality care, treatment, and prevention services for individuals affected by HIV. Interested applicants, including public and private nonprofits, state and local governments, and educational institutions, must submit their proposals by March 18, 2025, with the funded program expected to commence on September 1, 2025. For further inquiries, contact LaQuanta Smalley at SPNS@hrsa.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement for NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R01)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the initiative titled "NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use," aimed at addressing HIV-related health disparities in underserved racial and/or ethnic populations. This funding opportunity will solicit research applications that propose novel approaches to tackle these critical health issues, with a focus on fostering meaningful collaborations among applicants. The estimated total program funding for this initiative is $2,000,000, with the NOFO expected to be published in Summer 2025 and applications due in Winter 2025. Interested researchers should prepare to submit their proposals by the anticipated deadlines, with awards expected to be made by July 1, 2026.
    Notice of Intent to Publish a Funding Opportunity Announcement for NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use: Novel Approaches to Address HIV Related Health Disparities in Underserved Racial and/or Ethnic Populations (R34)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) for the initiative titled "NIDA REI: Reaching Equity at the Intersection of HIV and Substance Use," aimed at addressing HIV-related health disparities in underserved racial and ethnic populations. This initiative seeks to solicit research applications that propose novel approaches to tackle these critical health issues, thereby promoting equity in health outcomes. The estimated total program funding for this opportunity is $2,000,000, with the NOFO expected to be published in Summer 2025 and applications due in Winter 2025. Interested applicants should prepare to submit their proposals by the anticipated deadlines, with awards expected to be made by July 1, 2026.